Agent chemotherapy regimens. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Bone Marrow Tumor Cells, Cultured

Diseases81

Breast Neoplasms Lung Neoplasms Lymphoma, Non-Hodgkin Neutropenia Neoplasm Recurrence, Local Hodgkin Disease Nausea Neoplasm Metastasis Vomiting Carcinoma, Non-Small-Cell Lung Neoplasms Testicular Neoplasms Colorectal Neoplasms Ovarian Neoplasms Leukopenia Neoplasms, Germ Cell and Embryonal Adenocarcinoma Recurrence Disease Progression Thrombocytopenia Hematologic Diseases Bone Neoplasms Lymphoma, Large B-Cell, Diffuse Brain Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Liver Neoplasms Lymphoma Peritoneal Neoplasms Osteosarcoma Stomach Neoplasms Carcinoma Lymphatic Metastasis Germinoma Mediastinal Neoplasms Lymphoma, Follicular Lymphoma, B-Cell Carcinoma, Small Cell Seminoma Head and Neck Neoplasms Fever Carcinoma, Squamous Cell Central Nervous System Neoplasms Retroperitoneal Neoplasms Leukemia, Myeloid, Acute Stomatitis Bone Marrow Diseases Sarcoma Biliary Tract Neoplasms Burkitt Lymphoma Neoplasms, Unknown Primary Alopecia Lymphoma, Mantle-Cell Urologic Neoplasms Sarcoma, Ewing Neoplasm, Residual Mesothelioma Pancreatic Neoplasms Amenorrhea Neoplasms, Second Primary Medulloblastoma Pleural Neoplasms Multiple Myeloma Rectal Neoplasms Leukemia, Myeloid Leukemia Esophageal Neoplasms Lymphoma, AIDS-Related Colonic Neoplasms Urinary Bladder Neoplasms Carcinoma, Transitional Cell Astrocytoma Anemia Glioblastoma Acute Disease Glioma Fatigue Agranulocytosis Melanoma Peripheral Nervous System Diseases Neuroblastoma Diarrhea

Chemicals and Drugs75

Cyclophosphamide Cisplatin Doxorubicin Etoposide Antineoplastic Agents Vincristine Methotrexate Bleomycin Vinblastine Ifosfamide Taxoids Paclitaxel Anthracyclines Deoxycytidine Carboplatin Organoplatinum Compounds Fluorouracil Cytarabine Antimetabolites, Antineoplastic Lomustine Prednisone Antineoplastic Agents, Alkylating Antineoplastic Agents, Phytogenic Granulocyte Colony-Stimulating Factor Camptothecin Dacarbazine Epirubicin Mitoxantrone Procarbazine Leucovorin Antibodies, Monoclonal, Humanized Antiemetics Bridged Compounds Carmustine Antibiotics, Antineoplastic Melphalan Mesna Platinum Compounds Mitomycin Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Tegafur Vindesine Thiotepa Dexamethasone Altretamine Prednisolone Tumor Markers, Biological Daunorubicin Prochlorperazine Oxonic Acid Receptor, erbB-2 Fluoxymesterone Topotecan Quinazolines Mechlorethamine Platinum Idarubicin Asparaginase Angiogenesis Inhibitors Mitomycins Vidarabine Drug Combinations Tamoxifen Antineoplastic Agents, Hormonal Recombinant Proteins Receptors, Estrogen Dactinomycin Receptors, Progesterone Guanine Receptor, Epidermal Growth Factor Protein Kinase Inhibitors Glutamates Antigens, CD34 Busulfan

Analytical, Diagnostic and Therapeutic Techniques and Equipment79

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Treatment Outcome Combined Modality Therapy Drug Administration Schedule Disease-Free Survival Survival Analysis Survival Rate Neoplasm Staging Prognosis Salvage Therapy Neoadjuvant Therapy Infusions, Intravenous Follow-Up Studies Transplantation, Autologous Clinical Trials as Topic Prospective Studies Remission Induction Radiotherapy, Adjuvant Hematopoietic Stem Cell Transplantation Drug Evaluation Randomized Controlled Trials as Topic Kaplan-Meier Estimate Actuarial Analysis Clinical Trials, Phase III as Topic Retrospective Studies Induction Chemotherapy Radiotherapy Radiotherapy Dosage Administration, Oral Palliative Care Drug Therapy Multivariate Analysis Pilot Projects Clinical Trials, Phase II as Topic Cranial Irradiation Drug Therapy, Combination Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Feasibility Studies Treatment Failure Infusions, Intra-Arterial Maximum Tolerated Dose Proportional Hazards Models Chemotherapy, Cancer, Regional Perfusion Chemoradiotherapy Risk Factors Leukapheresis Random Allocation Drug Screening Assays, Antitumor Peripheral Blood Stem Cell Transplantation Stem Cell Transplantation Retreatment Radioimmunotherapy Blood Cell Count Transplantation Conditioning Karnofsky Performance Status Immunohistochemistry Predictive Value of Tests Life Tables Cohort Studies Double-Blind Method Injections, Intravenous Tomography, X-Ray Computed Risk Assessment Patient Selection Immunotherapy Xenograft Model Antitumor Assays Probability Transplantation, Homologous Leukocyte Count Molecular Targeted Therapy Maintenance Chemotherapy Drug Approval Hyperthermia, Induced Meta-Analysis as Topic Analysis of Variance Confidence Intervals Incidence

Phenomena and Processes12

Drug Resistance, Neoplasm Dose-Response Relationship, Drug Time Factors Maximum Tolerated Dose Drug Synergism Blood Cell Count Drug Resistance, Multiple Apoptosis Probability Leukocyte Count Premenopause Gene Expression Regulation, Neoplastic

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Drug Approval

Humanities1

Quality of Life

Information Science4

Survival Rate Informatics Life Tables Incidence

Health Care34

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Clinical Trials as Topic Prospective Studies Randomized Controlled Trials as Topic Kaplan-Meier Estimate Actuarial Analysis Clinical Trials, Phase III as Topic Retrospective Studies Palliative Care Multivariate Analysis Pilot Projects Clinical Trials, Phase II as Topic Feasibility Studies Treatment Failure Proportional Hazards Models Risk Factors Random Allocation Age Factors Karnofsky Performance Status Predictive Value of Tests Life Tables Cohort Studies Double-Blind Method Risk Assessment Patient Selection Probability Meta-Analysis as Topic Analysis of Variance Confidence Intervals Incidence

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Cyclophosphamide Cisplatin Doxorubicin Treatment Outcome Combined Modality Therapy Etoposide Antineoplastic Agents Drug Administration Schedule Disease-Free Survival Survival Analysis Vincristine Methotrexate Bleomycin Vinblastine Survival Rate Ifosfamide Taxoids Paclitaxel Breast Neoplasms Neoplasm Staging Lung Neoplasms Prognosis Anthracyclines Deoxycytidine Salvage Therapy Carboplatin Neoadjuvant Therapy Lymphoma, Non-Hodgkin Organoplatinum Compounds Fluorouracil Neutropenia Neoplasm Recurrence, Local Cytarabine Hodgkin Disease Nausea Infusions, Intravenous Antimetabolites, Antineoplastic Neoplasm Metastasis Lomustine Vomiting Drug Resistance, Neoplasm Prednisone Follow-Up Studies Antineoplastic Agents, Alkylating Antineoplastic Agents, Phytogenic Carcinoma, Non-Small-Cell Lung Granulocyte Colony-Stimulating Factor Camptothecin Transplantation, Autologous Dacarbazine Neoplasms Epirubicin Dose-Response Relationship, Drug Mitoxantrone Testicular Neoplasms Procarbazine Colorectal Neoplasms Ovarian Neoplasms Leucovorin Time Factors Clinical Trials as Topic Leukopenia Neoplasms, Germ Cell and Embryonal Antibodies, Monoclonal, Humanized Prospective Studies Remission Induction Radiotherapy, Adjuvant Antiemetics Bridged Compounds Carmustine Adenocarcinoma Recurrence Antibiotics, Antineoplastic Hematopoietic Stem Cell Transplantation Drug Evaluation Melphalan Randomized Controlled Trials as Topic Kaplan-Meier Estimate Mesna Disease Progression Platinum Compounds Mitomycin Actuarial Analysis Antibodies, Monoclonal Clinical Trials, Phase III as Topic Antibodies, Monoclonal, Murine-Derived Thrombocytopenia Hematologic Diseases Bone Neoplasms Retrospective Studies Lymphoma, Large B-Cell, Diffuse Brain Neoplasms Induction Chemotherapy Precursor Cell Lymphoblastic Leukemia-Lymphoma Liver Neoplasms Radiotherapy Radiotherapy Dosage Tegafur

No FAQ available that match "agent chemotherapy regimens"